S&P 500   4,409.59
DOW   34,299.12
QQQ   367.93
UN steps up criticism of IMF and World Bank, the other pillars of the post-World War II global order
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
MarketBeat Week in Review – 6/12 - 6/16
Microsoft says early June disruptions to Outlook, cloud platform, were cyberattacks
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Government shutdown warnings rise as Republicans seek deeper cuts in budget battle
Eviction filings are 50% higher than they were pre-pandemic in some cities as rents rise
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Spain's Socialists have won the Barcelona mayor's office after getting help from conservative rivals
Thousands have protested against Serbia's president and pledged to 'radicalize' gatherings
S&P 500   4,409.59
DOW   34,299.12
QQQ   367.93
UN steps up criticism of IMF and World Bank, the other pillars of the post-World War II global order
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
MarketBeat Week in Review – 6/12 - 6/16
Microsoft says early June disruptions to Outlook, cloud platform, were cyberattacks
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Government shutdown warnings rise as Republicans seek deeper cuts in budget battle
Eviction filings are 50% higher than they were pre-pandemic in some cities as rents rise
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Spain's Socialists have won the Barcelona mayor's office after getting help from conservative rivals
Thousands have protested against Serbia's president and pledged to 'radicalize' gatherings
S&P 500   4,409.59
DOW   34,299.12
QQQ   367.93
UN steps up criticism of IMF and World Bank, the other pillars of the post-World War II global order
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
MarketBeat Week in Review – 6/12 - 6/16
Microsoft says early June disruptions to Outlook, cloud platform, were cyberattacks
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Government shutdown warnings rise as Republicans seek deeper cuts in budget battle
Eviction filings are 50% higher than they were pre-pandemic in some cities as rents rise
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Spain's Socialists have won the Barcelona mayor's office after getting help from conservative rivals
Thousands have protested against Serbia's president and pledged to 'radicalize' gatherings
S&P 500   4,409.59
DOW   34,299.12
QQQ   367.93
UN steps up criticism of IMF and World Bank, the other pillars of the post-World War II global order
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
MarketBeat Week in Review – 6/12 - 6/16
Microsoft says early June disruptions to Outlook, cloud platform, were cyberattacks
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Government shutdown warnings rise as Republicans seek deeper cuts in budget battle
Eviction filings are 50% higher than they were pre-pandemic in some cities as rents rise
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Spain's Socialists have won the Barcelona mayor's office after getting help from conservative rivals
Thousands have protested against Serbia's president and pledged to 'radicalize' gatherings
OTCMKTS:CVSI

CV Sciences (CVSI) Stock Forecast, Price & News

$0.04
0.00 (0.00%)
(As of 06/16/2023 ET)
Compare
Today's Range
$0.04
$0.04
50-Day Range
$0.04
$0.05
52-Week Range
$0.03
$0.07
Volume
264,324 shs
Average Volume
133,905 shs
Market Capitalization
$6.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CVSI stock logo

About CV Sciences (OTCMKTS:CVSI) Stock

CV Sciences, Inc. develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers. It is also developing cannabinoids intended to treat medical indications, including CVSI-007 that combines CBD and nicotine for the treatment of smokeless tobacco use and addiction. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.

CVSI Price History

CVSI Stock News Headlines

"Unknown laser company making HUGE profit from Russia-Ukraine War"
On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>
CV Sciences earnings: here's what Wall Street expects
CV Sciences, Inc. Introduces New THC Offering
"Unknown laser company making HUGE profit from Russia-Ukraine War"
On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>
Why Is CV Sciences Stock Up Today?
CV Sciences, Inc. (CVSI) Q3 2022 Earnings Call Transcript
CVSI CV Sciences, Inc.
CV Sciences, Inc. Extinguishes Convertible Debt
See More Headlines
Receive CVSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CV Sciences and its competitors with MarketBeat's FREE daily newsletter.

CVSI Company Calendar

Last Earnings
3/29/2023
Today
6/17/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:CVSI
Previous Symbol
NASDAQ:CVSI
Employees
42
Year Founded
N/A

Profitability

Net Income
$-8,210,000.00
Pretax Margin
-2.13%

Debt

Sales & Book Value

Annual Sales
$16.20 million
Book Value
($0.01) per share

Miscellaneous

Free Float
151,922,000
Market Cap
$6.10 million
Optionable
Not Optionable
Beta
0.96

Key Executives

  • Mr. Joseph D. Dowling (Age 66)
    CEO, Sec. & Director
    Comp: $298.98k
  • Mr. Joerg Grasser (Age 48)
    Chief Financial Officer
    Comp: $210.47k
  • Mr. Tim Hitchman
    VP of Operations
  • Mr. Jesse Karagianes
    Sr. VP of Revenue Growth
  • Ms. Alyssa Dunn
    Operations Mang.













CVSI Stock - Frequently Asked Questions

How have CVSI shares performed in 2023?

CV Sciences' stock was trading at $0.0324 on January 1st, 2023. Since then, CVSI shares have increased by 23.8% and is now trading at $0.0401.
View the best growth stocks for 2023 here
.

Are investors shorting CV Sciences?

CV Sciences saw a drop in short interest in the month of May. As of May 31st, there was short interest totaling 26,100 shares, a drop of 39.9% from the May 15th total of 43,400 shares. Based on an average daily volume of 385,600 shares, the days-to-cover ratio is currently 0.1 days.
View CV Sciences' Short Interest
.

How were CV Sciences' earnings last quarter?

CV Sciences, Inc. (OTCMKTS:CVSI) issued its quarterly earnings results on Wednesday, March, 29th. The company reported ($0.02) EPS for the quarter. The firm had revenue of $3.87 million for the quarter. CV Sciences had a negative trailing twelve-month return on equity of 15.47% and a negative net margin of 1.83%.

What other stocks do shareholders of CV Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CV Sciences investors own include Aurora Cannabis (ACB), Cronos Group (CRON), Charlotte's Web (CWBHF), KushCo (KSHB), Organigram (OGI), GW Pharmaceuticals (GWPH), Tilray (TLRY) and Medical Marijuana (MJNA).

What is CV Sciences' stock symbol?

CV Sciences trades on the OTCMKTS under the ticker symbol "CVSI."

How do I buy shares of CV Sciences?

Shares of CVSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CV Sciences' stock price today?

One share of CVSI stock can currently be purchased for approximately $0.04.

How much money does CV Sciences make?

CV Sciences (OTCMKTS:CVSI) has a market capitalization of $6.10 million and generates $16.20 million in revenue each year. The company earns $-8,210,000.00 in net income (profit) each year or ($0.02) on an earnings per share basis.

How can I contact CV Sciences?

CV Sciences' mailing address is 10070 BARNES CANYON ROAD, SAN DIEGO CA, 92121. The official website for the company is www.cvsciences.com. The company can be reached via phone at (866) 290-2157, via email at ir@cvsciences.com, or via fax at 619-876-4321.

This page (OTCMKTS:CVSI) was last updated on 6/17/2023 by MarketBeat.com Staff

My Account -